FDA Drug Application (021303) for ADDERALL XR 30 by SHIRE

Back to FDA Applications sponsored by SHIRE

Application Number021303
Product Number003
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage7.5MG;7.5MG;7.5MG;7.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameADDERALL XR 30
Active IngredientAMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Active IngredientCount
List of drugs with Active Ingredient AMPHETAMINE ASPARTATE15
List of drugs with Active Ingredient AMPHETAMINE SULFATE20
List of drugs with Active Ingredient DEXTROAMPHETAMINE SACCHARATE16
List of drugs with Active Ingredient DEXTROAMPHETAMINE SULFATE22


Back to FDA Applications sponsored by SHIRE